A. Ros et al. / Tetrahedron: Asymmetry 21 (2010) 1557–1562
1561
quenched with water (8 mL), and 1 M NaOH was added to the reac-
tion mixture until pH 12. The mixture was extracted with CH2Cl2
(3 ꢃ 10 mL) and the combinedorganic layer was dried (MgSO4), con-
centrated to dryness, and the resulting residue was purified by flash
chromatography (1:1?5:1 EtOAc–hexane) to give 5 (59 mg, 21%).
1H NMR (300 MHz, CDCl3): d 7.59 (s, 1H), 7.40–7.15 (m, 5H), 7.04
(s, 2H), 3.55–3.40 (m, 1H), 3.30 (dq, 1H, J = 8.1, 3.3 Hz), 3.12 (q, 1H,
J = 8.7 Hz), 2.94 (dd, 1H, J = 13.2, 3.6 Hz), 2.76 (dd, 1H, J = 13.2,
5.4 Hz), 2.25–2.15 (m, 1H), 2.00–1.80 (m, 2H), 1.80–1.65 (m, 1H).
13C NMR (75 MHz, CDCl3): d 137.2, 136.1, 129.3, 129.2, 128.9,
and the reaction crude was purified by flash chromatography (10:1
CH2Cl2–MeOH) to give complex 8 as a yellow solid (236 mg, 63%
yield). X-ray quality crystals were grown by slow diffusion of ethyl
ether into a solution of the complex in CH2Cl2. Mp 158–161 °C. 1
H
NMR (300 MHz, CDCl3):
d 7.50–7.35 (m, 6H), 7.11 (d, 1H,
J = 2.1 Hz), 5.05 (m, 1H), 4.45–4.38 (m, 2H), 4.22–4.14 (m, 1H),
4.14–4.08 (m, 1H), 3.62–3.53 (m, 1H), 3.43–3.31 (m, 3H), 2.76
(dd, 1H, J = 12.0, 2.1 Hz), 2.52–2.44 (m, 2H), 2.30–2.10 (m, 7H),
1.90–1.80 (m, 3H), 1.49 (d, 3H, J = 6.6 Hz), 1.47 (d, 3H, J = 6.6 Hz).
13C NMR (75 MHz, CDCl3): d 174.9 (d, JC–Rh = 49 Hz), 131.4, 131.0,
130.4, 130.1, 119.7, 117.6, 95.6 (d, JC–Rh = 8 Hz), 94.1 (d, JC–
Rh = 7 Hz), 84.6 (d, JC–Rh = 12 Hz), 78.2 (d, JC–Rh = 12 Hz), 64.2, 53.0,
126.4, 114.9, 65.7, 57.3, 37.0, 28.6, 21.2. ½a D20
¼ ꢂ37:0 (c 0.8, CHCl3).
ꢁ
Anal. Calcd for C14H17N3S: C, 64.83; H, 6.61; N, 16.20. Found: C,
64.70; H, 6.85; N, 16.01.
52.9, 44.3, 34.3, 31.6, 30.5, 27.8, 24.7, 23.6, 21.8. ½a D20
¼ þ50:0 (c
ꢁ
0.1, MeOH). Anal. Calcd for C25H35F6N3RhSSb: C, 40.13; H, 4.71;
N, 5.62. Found: C, 40.03; H, 4.62; N, 5.64.
4.1.4. (2S)-3-Isopropyl-1-{2-[(phenylthio)methyl]pyrrolidin-1-
yl}-1H-imidazol-3-ium iodide 6
At first, 2-iodopropane (117
l
L, 1.17 mmol) was added to a
4.1.7. 1-[(R)-2-(Cyclohexylthio)-3-methylbutyl]-3-[(2S,5S)-2,5-
diphenylpyrrolidin-1-yl]-imidazol-2-ylidene (1,5-cyclooctadi-
ene)rhodium(I) bromide
solution of 5 (100 mg, 0.39 mmol) in THF (0.5 mL) and the reaction
mixture was stirred at 60 °C for 2 d. The solvent was removed in
vacuo and the resulting residue was purified by flash chromatogra-
phy (10:1 CH2Cl2/MeOH) to give 6 (122 mg, 73%) as a light yellow
oil. 1H NMR (300 MHz, CDCl3): d 10.08 (s, 1H), 7.62 (s, 1H), 7.45 (s,
1H), 7.40–7.20 (m, 4H), 7.18–7.05 (m, 1H), 4.92 (m, 1H), 3.95–3.75
(m, 1H), 3.70–3.45 (m, 3H), 3.03 (dd, 1H, J = 12.6, 5.2 Hz), 2.45–2.35
(m, 1H), 2.20–2.10 (m, 1H), 1.95–1.85 (m, 1H), 1.85–1.75 (m, 1H),
1.59 (d, 6H, J = 6.8 Hz). 13C NMR (75 MHz, CDCl3): d 136.2, 136.0,
129.9, 129.5, 126.9, 122.4, 119.1, 66.3, 58.8, 54.4, 38.3, 29.0, 23.4,
Compound 12: tBuONa (6 mg, 0.05 mmol) was added to a slurry
of [RhCl(COD)]2 (14 mg, 0.025 mmol) in dry THF (0.1 mL) and the
resulting solution was stirred for 30 min at room temperature un-
der argon. A solution of 11 (30 mg, 0.05 mol) in dry THF (0.5 mL)
was then added via a cannula and the reaction mixture was stirred
overnight. The solvent was evaporated in vacuo and the reaction
crude was purified by flash column chromatography (1:1 EtOAc–
hexane) to afford rhodium carbene 12 (34 mg, 89% yield, de
>98%) as a yellow syrup. 1H NMR (400 MHz, CDCl3): d 7.40 (d,
2H, J = 6.8 Hz), 7. 35 (d, 2H, J = 6.8 Hz), 7.25–7.13 (m, 6H), 6.46 (s,
1H), 6.04 (d, 1H, J = 2.0 Hz), 5.79 (br s, 1H), 5.08 (m, 1H), 4.96 (m,
1H), 4.60 (dd, 1H, J = 14.0, 6.8 Hz), 4.40 (t, 1H, J = 8.0 Hz), 4.25
(dd, 1H, J = 14.0, 10.0 Hz), 3.69 (t, 1H, J = 8.0 Hz), 3.50 (m, 1H),
3.05 (m, 1H), 2.83 (m, 1H), 2.73–2.62 (m, 2H), 2.52 (m, 1H),
2.44–2.14 (m, 6H), 2.12–2.00 (m, 4H), 1.87–1.62 (m, 8H), 1.40–
1.25 (m, 2H), 1.14 (d, 3H, J = 6.8 Hz), 0.84 (d, 3H, J = 6.8 Hz). 13C
NMR (100 MHz, CDCl3): d 181 (d, JC–Rh = 51 Hz), 139.3, 138.6,
129.2, 128.8, 128.3, 128.1, 128.0, 119.7, 116.1, 96.2, 95.4, 71.0 (br
s), 67.9, 63.0, 55.6, 51.1, 44.7, 34.7, 34.4, 33.6, 31.9, 31.7, 29.9,
21.8. ½a 2D0
¼ ꢂ25:0 (c 0.3, CHCl3). Anal. Calcd for C17H24N3IS: C,
ꢁ
47.55; H, 5.63; N, 9.79. Found: C, 47.30; H, 5.42; N, 9.71.
4.1.5. (Ra)- and (Sa)-1-Isopropyl-3-{(2S)-2-[(phenylthio)methyl]
pyrrolidin-1-yl}-imidazol-2-ilydene (1,5-cyclooctadiene)
rhodium(I) iodide 7
At first, tBuONa (48 mg, 0.5 mmol) was added to a slurry of
[RhCl(COD)]2 (123 mg, 0.25 mmol) in dry THF (2 mL) under an ar-
gon atmosphere. The resulting solution was stirred for 30 min and
then a solution of 6 (214 mg, 0.5 mol) in dry THF (2 mL) was added
via a cannula. The reaction mixture was stirred under argon over-
night at room temperature, the solvent was removed in vacuo, and
the resulting residue was purified by flash chromatography (1:1
EtOAc–hexane) to afford an inseparable mixture of diastereomers
(de ꢄ4%) of the rhodium carbene 7 as a yellow foam (291 mg,
91% yield). 1H NMR (500 MHz, CDCl3): d 7.34 (d, 2H, J = 9.2 Hz),
7.28–7.20 (m, 4H), 7.20–7.12 (m, 2H), 7.09 (t, 1H, J = 7.9 Hz), 6.99
(d, 1H, J = 2.0 Hz), 6.91 (d, 1H, J = 2.0 Hz), 6.88 (d, 1H, J = 2.0 Hz),
6.73 (d, 1H, J = 2.0 Hz), 5.83 (m, 1H), 5.72 (m, 1H), 5.22–5.12 (m,
4H), 4.16–4.07 (m, 1H), 3.86–3.78 (m, 2H), 3.76–3.70 (m, 1H),
3.72–3.66 (m, 2H), 3.58–3.50 (m, 1H), 3.50–3.46 (m, 1H), 3.44–
3.39 (m, 1H), 3.30 (q, 1H, J = 8.5 Hz), 3.13 (dd, 1H, J = 8.0, 4.5 Hz),
3.11–3.03 (m, 2H), 2.92 (dd, 1H, J = 13.0, 9.5 Hz), 2.40–2.30 (m,
4H), 2.30–2.15 (m, 6H), 2.10–1.90 (m, 6H), 1.90–1.70 (m, 9H),
1.60–1.40 (m, 12H). 13C NMR (75 MHz, CDCl3): d 182.2 (d, JRh–
C = 50 Hz), 180.9 (d, JRh–C = 49 Hz), 137.0, 136.6, 129.5, 129.3,
129.1, 129.0, 126.5, 125.6, 118.0, 117.6, 116.6, 115.9, 99.9, 99.8,
99.7, 77.5, 71.9, 71.8, 71.7, 71.6, 71.5, 71.3, 71.1, 66.1, 62.8, 58.0,
57.6, 53.8, 39.1, 38.0, 37.5, 33.7, 31.5, 31.4, 30.9, 30.7, 29.4, 29.2,
29.0, 24.1, 24.0, 23.2, 23.1, 22.3, 21.1; Anal. Calcd for C25H35N3RhIS:
C, 46.96; H, 5.52; N, 6.57. Found: C, 46.76; H, 5.34; N, 6.41.
28.8, 27.8, 26.5, 26.2, 25.8, 25.7, 20.8, 16.4. ½a D20
¼ ꢂ160:0 (c 0.2,
ꢁ
CHCl3). MS (FAB): m/z (%) = 684 (10, M+–Br), 576 (30), 133 (100).
HRMS (FAB) m/z calcd for C38H51N3SRh 684.2859, found 684.2846.
4.1.8. (Sa,SS)-{1-[(R)-2-(Cyclohexylthio)-3-methylbutyl]-3-[(2S,
5S)-2,5-diphenylpyrrolidin-1-yl]-imidazol-2-ylidene}(1,5-cyclo-
octadiene)rhodium(I) hexafluorophosphate (Sa,SS)-13
Method A: At first, silver (I) oxide (23 mg, 0.1 mmol) was added
to a solution of the imidazolium bromide 11 (111 mg, 0.2 mmol) in
dry CH2Cl2 (3 mL) under argon and was stirred in the dark for 2 h.
The reaction mixture was then filtered through Celite, washed with
CH2Cl2, and concentrated in vacuo to give the silver carbene
(134 mg, 99%). To a solution of this material (82 mg, 0.17 mmol)
in dry CH2Cl2 (2 mL) was added via a cannula a solution of rhodium
biscyclooctadiene hexafluorophosphate (79 mg, 0.17 mmol) in dry
CH2Cl2 (3 mL) under an argon atmosphere. The mixture was stirred
in the dark for 1 h, filtered through Celite, washed with CH2Cl2, and
concentrated in vacuo. Purification of the resulting residue by flash
chromatography (20:1 CH2Cl2–MeOH) gave a yellow oil which was
triturated with pentane to give (Sa,SS)-13 (130 mg, 92% yield) as a
yellow solid. Mp 132–134 °C. 1H NMR (400 MHz, CDCl3): d 7.43–
7.37 (br s, 4H), 7.32 (d, 2H, J = 8.0 Hz), 7.21–7.13 (m, 4H), 6.95
(br s, 2H), 6.87 (s, 1H), 6.16 (br s, 1H), 5.95 (s, 1H), 4.83 (m, 0.5H),
4.78 (br s, 1H), 4.56 (m, 1H), 4.49 (m, 1H), 4.32 (t, 1H, J = 8.4 Hz),
4.29–4.18 (m, 2.5 H), 2.84 (br s, 1H), 2.73–2.61 (m, 3H), 2.60–2.25
(m, 8H), 2.22–2.08 (m, 4H), 2.05–1.91 (m, 1H), 1.88–1.75 (m, 2H),
1.40–1.20 (m, 4H), 1.03 (d, 3H, J = 6.4 Hz), 0.97 (d, 3H, J = 6.4 Hz).
13C NMR (125 MHz, CDCl3): d 171.8 (d, JC–Rh = 52.0 Hz), 137.0,
4.1.6. (2S,Ra,SS)-1-Isopropyl-3-{2-[(phenylthio)methyl]
pyrrolidin-1-yl}-imidazol-2-ilydene (1,5-cyclooctadiene)
rhodium(I) hexafluoroantimonate
(Ra,SS)-8: At first, AgSbF6 (171 mg, 0.5 mmol) was added to a
solution of the diastereomeric mixture of (Ra/Sa)-7 (340 mg,
0.5 mmol) in dry CH2Cl2 (3 mL) and the mixture was stirred in dark
at room temperature for 1 h. The solvent was evaporated in vacuo